A haemagglutination test for rapid detection of antibodies to SARS-CoV-2.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
29 03 2021
Historique:
received: 13 10 2020
accepted: 17 02 2021
entrez: 30 3 2021
pubmed: 31 3 2021
medline: 10 4 2021
Statut: epublish

Résumé

Serological detection of antibodies to SARS-CoV-2 is essential for establishing rates of seroconversion in populations, and for seeking evidence for a level of antibody that may be protective against COVID-19 disease. Several high-performance commercial tests have been described, but these require centralised laboratory facilities that are comparatively expensive, and therefore not available universally. Red cell agglutination tests do not require special equipment, are read by eye, have short development times, low cost and can be applied at the Point of Care. Here we describe a quantitative Haemagglutination test (HAT) for the detection of antibodies to the receptor binding domain of the SARS-CoV-2 spike protein. The HAT has a sensitivity of 90% and specificity of 99% for detection of antibodies after a PCR diagnosed infection. We will supply aliquots of the test reagent sufficient for ten thousand test wells free of charge to qualified research groups anywhere in the world.

Identifiants

pubmed: 33782398
doi: 10.1038/s41467-021-22045-y
pii: 10.1038/s41467-021-22045-y
pmc: PMC8007702
doi:

Substances chimiques

Antibodies, Monoclonal 0
Antibodies, Viral 0
Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1951

Subventions

Organisme : Department of Health
ID : 200927
Pays : United Kingdom
Organisme : Department of Health
ID : IS-BRC-1215-20013
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : HHSN272201400008C
Pays : United States
Organisme : Wellcome Trust
ID : 110110Z/15/Z
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C18616/A25153
Pays : United Kingdom
Organisme : Department of Health
ID : 200907
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT204969/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 095541/A/11/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 109965/Z/15/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P021336/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L006588/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19059
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 205228/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19025
Pays : United Kingdom

Références

Nature. 2020 Aug;584(7821):437-442
pubmed: 32555388
Cell. 2020 Nov 25;183(5):1367-1382.e17
pubmed: 33160446
Nature. 2020 Jul;583(7815):290-295
pubmed: 32422645
Nat Med. 2020 Jul;26(7):1033-1036
pubmed: 32398876
PLoS Med. 2006 Jul;3(7):e237
pubmed: 16796401
Nat Struct Mol Biol. 2020 Oct;27(10):950-958
pubmed: 32737466
Cell Host Microbe. 2020 Sep 9;28(3):497
pubmed: 32910920
Transfusion. 1961 Jan-Feb;1:5-8
pubmed: 13758692
Br J Haematol. 2003 May;121(4):556-65
pubmed: 12752096
Br J Haematol. 2007 Jun;137(5):401-8
pubmed: 17488485
Science. 1941 Jul 4;94(2427):22-3
pubmed: 17777315
Wellcome Open Res. 2020 Jun 11;5:139
pubmed: 33748431
Nature. 2020 Oct;586(7830):572-577
pubmed: 32726802
Lancet Infect Dis. 2020 Dec;20(12):1390-1400
pubmed: 32979318
Clin Infect Dis. 2020 Sep 12;:
pubmed: 32918466
Br J Exp Pathol. 1945;26:255-66
pubmed: 21006651
Nat Struct Mol Biol. 2020 Sep;27(9):846-854
pubmed: 32661423
Cell. 2020 Aug 6;182(3):722-733.e11
pubmed: 32645327
Nat Biotechnol. 2020 Sep;38(9):1073-1078
pubmed: 32704169
Nature. 2020 Oct;586(7830):589-593
pubmed: 32785213
Anal Biochem. 2013 Jul 1;438(1):82-9
pubmed: 23541519
Science. 2005 Sep 16;309(5742):1864-8
pubmed: 16166518
Nat Commun. 2021 Jan 22;12(1):542
pubmed: 33483491
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
Nat Immunol. 2020 Nov;21(11):1336-1345
pubmed: 32887977
Cell. 2020 Aug 20;182(4):828-842.e16
pubmed: 32645326
Cell. 2020 Nov 12;183(4):1024-1042.e21
pubmed: 32991844
Cell. 2020 May 14;181(4):894-904.e9
pubmed: 32275855
Biochem Biophys Res Commun. 2021 May 14;553:165-171
pubmed: 33773139
Cell. 2020 Jun 11;181(6):1436-1441
pubmed: 32531248

Auteurs

Alain Townsend (A)

MRC Human Immunology Unit, MRC Weatherall Institute, John Radcliffe Hospital, Oxford, UK. alain.townsend@imm.ox.ac.uk.
Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK. alain.townsend@imm.ox.ac.uk.

Pramila Rijal (P)

MRC Human Immunology Unit, MRC Weatherall Institute, John Radcliffe Hospital, Oxford, UK.
Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.

Julie Xiao (J)

MRC Human Immunology Unit, MRC Weatherall Institute, John Radcliffe Hospital, Oxford, UK.

Tiong Kit Tan (TK)

MRC Human Immunology Unit, MRC Weatherall Institute, John Radcliffe Hospital, Oxford, UK.

Kuan-Ying A Huang (KA)

Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan.

Lisa Schimanski (L)

MRC Human Immunology Unit, MRC Weatherall Institute, John Radcliffe Hospital, Oxford, UK.
Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.

Jiandong Huo (J)

Structural Biology, The Rosalind Franklin Institute, Didcot, UK.

Nimesh Gupta (N)

Vaccine Immunology Laboratory, National Institute of Immunology, New Delhi, India.

Rolle Rahikainen (R)

Department of Biochemistry, University of Oxford, Oxford, UK.

Philippa C Matthews (PC)

Department of Microbiology and Infectious Diseases, John Radcliffe Hospital, Oxford, UK.
Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Derrick Crook (D)

Department of Microbiology and Infectious Diseases, John Radcliffe Hospital, Oxford, UK.
Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Oxford NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.

Sarah Hoosdally (S)

Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Oxford NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.

Susanna Dunachie (S)

Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Eleanor Barnes (E)

Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.

Teresa Street (T)

Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Oxford NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.

Christopher P Conlon (CP)

Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.

John Frater (J)

Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.

Carolina V Arancibia-Cárcamo (CV)

Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.

Justine Rudkin (J)

Nuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford, USA.

Nicole Stoesser (N)

Department of Microbiology and Infectious Diseases, John Radcliffe Hospital, Oxford, UK.
Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.

Fredrik Karpe (F)

Oxford NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.
Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Matthew Neville (M)

Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Rutger Ploeg (R)

Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.

Marta Oliveira (M)

Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.

David J Roberts (DJ)

NHS Blood and Transplant, John Radcliffe Hospital, Oxford, UK.
BRC Haematology Theme and Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, USA.

Abigail A Lamikanra (AA)

NHS Blood and Transplant, John Radcliffe Hospital, Oxford, UK.

Hoi Pat Tsang (HP)

NHS Blood and Transplant, John Radcliffe Hospital, Oxford, UK.

Abbie Bown (A)

Public Health England, Salisbury, UK.

Richard Vipond (R)

Public Health England, Salisbury, UK.

Alexander J Mentzer (AJ)

Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.

Julian C Knight (JC)

Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.
Oxford NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.
Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.

Andrew J Kwok (AJ)

Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.

Gavin R Screaton (GR)

Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Division of Medical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.

Juthathip Mongkolsapaya (J)

Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.
Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Dengue Hemorrhagic Fever Research Unit, Office for Research and Development, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Wanwisa Dejnirattisai (W)

Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.

Piyada Supasa (P)

Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.

Paul Klenerman (P)

Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Christina Dold (C)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
NIHR Oxford Biomedical Research Centre, Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, UK.

J Kenneth Baillie (JK)

Genetics and Genomics, Roslin Institute, University of Edinburgh, Edinburgh, UK.

Shona C Moore (SC)

NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.

Peter J M Openshaw (PJM)

National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, UK.

Malcolm G Semple (MG)

NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.

Lance C W Turtle (LCW)

NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.

Mark Ainsworth (M)

Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Alice Allcock (A)

Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.

Sally Beer (S)

Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Sagida Bibi (S)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.

Donal Skelly (D)

Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Lizzy Stafford (L)

Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Katie Jeffrey (K)

Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Denise O'Donnell (D)

Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Elizabeth Clutterbuck (E)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.

Alexis Espinosa (A)

Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Maria Mendoza (M)

Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Dominique Georgiou (D)

Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Teresa Lockett (T)

Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Jose Martinez (J)

Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Elena Perez (E)

Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Veronica Gallardo Sanchez (V)

Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Giuseppe Scozzafava (G)

Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Alberto Sobrinodiaz (A)

Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Hannah Thraves (H)

Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Etienne Joly (E)

Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France. atnjoly@mac.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH